Cargando…

Erythrocytes in multiple sclerosis – forgotten contributors to the pathophysiology?

Multiple sclerosis (MS) is an autoimmune disease characterised by lymphocytic infiltration of the central nervous system and subsequent destruction of myelin and axons. On the background of a genetic predisposition to autoimmunity, environmental triggers are assumed to initiate the disease. The majo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Groen, Kira, Maltby, Vicki E, Sanders, Katherine A, Scott, Rodney J, Tajouri, Lotti, Lechner-Scott, Jeannette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433403/ https://www.ncbi.nlm.nih.gov/pubmed/28607726 http://dx.doi.org/10.1177/2055217316649981

Ejemplares similares

Erythrocyte microRNAs show biomarker potential and implicate multiple sclerosis susceptibility genes
por: Groen, Kira, et al.
Publicado: (2020)

Erythrocyte microRNA sequencing reveals differential expression in relapsing-remitting multiple sclerosis
por: Groen, Kira, et al.
Publicado: (2018)

Genome-wide DNA methylation changes in CD19(+) B cells from relapsing-remitting multiple sclerosis patients
por: Maltby, Vicki E., et al.
Publicado: (2018)

Genome-wide DNA methylation profiling of CD8+ T cells shows a distinct epigenetic signature to CD4+ T cells in multiple sclerosis patients
por: Maltby, Vicki E., et al.
Publicado: (2015)

Next-generation sequencing reveals broad down-regulation of microRNAs in secondary progressive multiple sclerosis CD4+ T cells
por: Sanders, Katherine A., et al.
Publicado: (2016)

Letter to the editor: blood processing and sample storage have negligible effects on methylation
por: Groen, Kira, et al.
Publicado: (2018)

Differential methylation at MHC in CD4(+) T cells is associated with multiple sclerosis independently of HLA-DRB1
por: Maltby, Vicki E., et al.
Publicado: (2017)

DNA methylation changes in CD4(+) T cells isolated from multiple sclerosis patients on dimethyl fumarate
por: Maltby, Vicki E, et al.
Publicado: (2018)

Epigenetic differences at the HTR2A locus in progressive multiple sclerosis patients
por: Maltby, Vicki E., et al.
Publicado: (2020)

The effect of cladribine on immunoglobulin levels compared to B cell targeting therapies in multiple sclerosis
por: Lycett, Mitchell J, et al.
Publicado: (2023)

Whole-blood methylation signatures are associated with and accurately classify multiple sclerosis disease severity
por: Campagna, Maria Pia, et al.
Publicado: (2022)

A comparison between the pathophysiology of multiple sclerosis and normal pressure hydrocephalus: is pulse wave encephalopathy a component of MS?
por: Bateman, Grant A., et al.
Publicado: (2016)

Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis
por: Xavier, Alexandre, et al.
Publicado: (2023)

Parity is associated with long-term differences in DNA methylation at genes related to neural plasticity in multiple sclerosis
por: Campagna, Maria Pia, et al.
Publicado: (2023)

Forgotten Contributors in the Brick Sector in Nepal
por: Bajracharya, Sugat B., et al.
Publicado: (2021)

Evaluation of Cell-Specific Epigenetic Age Acceleration in People With Multiple Sclerosis
por: Maltby, Vicki, et al.
Publicado: (2023)

Efficacy of Cladribine Tablets as a Treatment for People With Multiple Sclerosis: Protocol for the CLOBAS Study (Cladribine, a Multicenter, Long-term Efficacy and Biomarker Australian Study)
por: Maltby, Vicki E, et al.
Publicado: (2021)

Inflammatory Pathophysiology as a Contributor to Myeloproliferative Neoplasms
por: Fisher, Daniel Arthur Corpuz, et al.
Publicado: (2021)

2D in-vivo L-COSY spectroscopy identifies neurometabolite alterations in treated multiple sclerosis
por: Quadrelli, Scott, et al.
Publicado: (2019)

Increased DNA methylation of SLFN12 in CD4(+) and CD8(+) T cells from multiple sclerosis patients
por: Rhead, Brooke, et al.
Publicado: (2018)

DNA Methylation Signatures of Multiple Sclerosis Occur Independently of Known Genetic Risk and Are Primarily Attributed to B Cells and Monocytes
por: Xavier, Alexandre, et al.
Publicado: (2023)

Is multiple sclerosis a risk factor for infections?
por: Lechner-Scott, Jeannette, et al.
Publicado: (2020)

Capturing SNP Association across the NK Receptor and HLA Gene Regions in Multiple Sclerosis by Targeted Penalised Regression Models
por: Burnard, Sean M., et al.
Publicado: (2021)

Vaccine hesitancy in people with multiple sclerosis
por: Lechner-Scott, Jeannette S, et al.
Publicado: (2022)

Can a stress management programme reduce stress and improve quality of life in people diagnosed with multiple sclerosis?
por: Agland, Susan, et al.
Publicado: (2018)

Cognitive Contributors of Backward Walking in Persons with Multiple Sclerosis
por: Takla, Taylor N., et al.
Publicado: (2023)

Fast magnetic resonance spectroscopic imaging techniques in human brain- applications in multiple sclerosis
por: Al-iedani, Oun, et al.
Publicado: (2017)

Epigenome-wide association studies: current knowledge, strategies and recommendations
por: Campagna, Maria Pia, et al.
Publicado: (2021)

Air pollution as a contributor to the inflammatory activity of multiple sclerosis
por: Cortese, Andrea, et al.
Publicado: (2020)

Bronisława Fejgin (1883–1943): Forgotten Important Contributor to International Microbiology and Phage Therapy
por: Grzybowski, Andrzej, et al.
Publicado: (2021)

Modelling of the dilated sagittal sinuses found in multiple sclerosis suggests increased wall stiffness may be a contributing factor
por: Bateman, Grant Alexander, et al.
Publicado: (2022)

Cognitive Impairment in Multiple Sclerosis: A Forgotten Disability Remembered
por: Rahn, Kristen, et al.
Publicado: (2012)

Relapse recovery: The forgotten variable in multiple sclerosis clinical trials
por: Kantarci, Orhun H., et al.
Publicado: (2019)

COVID-19 vaccines and multiple sclerosis disease-modifying therapies
por: Giovannoni, Gavin, et al.
Publicado: (2021)

Matrix Metalloproteinase-9 as an Important Contributor to the Pathophysiology of Depression
por: Li, Hongmin, et al.
Publicado: (2022)

The Forgotten Brother: The Innate-like B1 Cell in Multiple Sclerosis
por: Halperin, Saar T., et al.
Publicado: (2022)

Prediction of Conversion from CIS to Clinically Definite Multiple Sclerosis Using Convolutional Neural Networks
por: Afzal, H. M. Rehan, et al.
Publicado: (2022)

Mast cells are major contributors to the pathophysiology of Graves’ Ophthalmopathy (GO)
por: Van Steensel, L, et al.
Publicado: (2010)

Changes in patient and physician attitudes resulting from COVID-19 in neuromyelitis optica spectrum disorder and multiple sclerosis
por: Salama, Sara, et al.
Publicado: (2020)

Cognitive dysfunction in multiple sclerosis: Usually forgotten in the clinical assessment of MS patients
por: Nabavi, Seyed Massood, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fk4oflj4u4j3qu51e4japapnlb